
D. Margaret M. Seaman
Examiner (ID: 10494, Phone: (571)272-0694 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625, 1203, 1621 |
| Total Applications | 3129 |
| Issued Applications | 2302 |
| Pending Applications | 276 |
| Abandoned Applications | 578 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18878972
[patent_doc_number] => 20240002341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS OF MAKING NICOTINIC ACID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/032842
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032842 | METHODS OF MAKING NICOTINIC ACID DERIVATIVES | Oct 21, 2021 | Pending |
Array
(
[id] => 18861764
[patent_doc_number] => 20230416199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => INHIBITORS OF AMINO ACID TRANSPORT
[patent_app_type] => utility
[patent_app_number] => 18/249142
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249142 | INHIBITORS OF AMINO ACID TRANSPORT | Oct 21, 2021 | Pending |
Array
(
[id] => 19629606
[patent_doc_number] => 20240408055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => USE OF ANISOMELIC ACID IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR INHIBITING INFECTION AND REPLICATION OF SARS-COV-2 AND VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/702340
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702340
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/702340 | USE OF ANISOMELIC ACID IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR INHIBITING INFECTION AND REPLICATION OF SARS-COV-2 AND VARIANTS | Oct 20, 2021 | Pending |
Array
(
[id] => 17656969
[patent_doc_number] => 20220177434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/506447
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506447 | Modulators of mas-related G-protein receptor X2 and related products and methods | Oct 19, 2021 | Issued |
Array
(
[id] => 18808527
[patent_doc_number] => 20230382860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => Bioactive Benzocycloheptene Analogues From Himachalenes and its Applications
[patent_app_type] => utility
[patent_app_number] => 18/032732
[patent_app_country] => US
[patent_app_date] => 2019-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032732
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032732 | Bioactive benzocycloheptene analogues from himachalenes and its applications | Oct 18, 2021 | Issued |
Array
(
[id] => 17761392
[patent_doc_number] => 20220235004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/499728
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499728 | Para acyl substituted diazacyclohexene derivatives | Oct 11, 2021 | Issued |
Array
(
[id] => 17368232
[patent_doc_number] => 20220023284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds
[patent_app_type] => utility
[patent_app_number] => 17/497201
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497201 | Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds | Oct 7, 2021 | Abandoned |
Array
(
[id] => 19034024
[patent_doc_number] => 20240083839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/030686
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030686 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS | Oct 5, 2021 | Pending |
Array
(
[id] => 17369855
[patent_doc_number] => 20220024907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
[patent_app_type] => utility
[patent_app_number] => 17/494370
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494370 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | Oct 4, 2021 | Abandoned |
Array
(
[id] => 17503268
[patent_doc_number] => 20220096370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => HIGH PENETRATION COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/493321
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493321 | HIGH PENETRATION COMPOSITION AND USES THEREOF | Oct 3, 2021 | Abandoned |
Array
(
[id] => 18725686
[patent_doc_number] => 20230339862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NOVEL DIBENZOACRIDINIUM DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/044829
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044829 | NOVEL DIBENZOACRIDINIUM DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS | Sep 13, 2021 | Pending |
Array
(
[id] => 17563082
[patent_doc_number] => 20220127231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PROCESS FOR THE PREPARTION OF AMIFAMPRIDINE PHOSPHATE
[patent_app_type] => utility
[patent_app_number] => 17/474087
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474087 | PROCESS FOR THE PREPARTION OF AMIFAMPRIDINE PHOSPHATE | Sep 13, 2021 | Abandoned |
Array
(
[id] => 18770756
[patent_doc_number] => 20230365540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => SMALL MOLECULE INHIBITORS OF ENPP1
[patent_app_type] => utility
[patent_app_number] => 18/025487
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025487
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025487 | SMALL MOLECULE INHIBITORS OF ENPP1 | Sep 8, 2021 | Abandoned |
Array
(
[id] => 18692442
[patent_doc_number] => 20230322682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 18/043971
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043971 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE | Sep 8, 2021 | Pending |
Array
(
[id] => 20578374
[patent_doc_number] => 12570616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Therapeutic compounds
[patent_app_type] => utility
[patent_app_number] => 18/023995
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1195
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023995
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023995 | Therapeutic compounds | Sep 7, 2021 | Issued |
Array
(
[id] => 18739470
[patent_doc_number] => 20230348394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHIES
[patent_app_type] => utility
[patent_app_number] => 18/025747
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025747 | COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHIES | Sep 7, 2021 | Pending |
Array
(
[id] => 17687610
[patent_doc_number] => 20220194902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs
[patent_app_type] => utility
[patent_app_number] => 17/466328
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466328 | Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs | Sep 2, 2021 | Abandoned |
Array
(
[id] => 18254252
[patent_doc_number] => 20230081291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => QUINOLINE cGAS ANTAGONIST COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/446951
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/446951 | Quinoline cGAS antagonist compounds | Sep 2, 2021 | Issued |
Array
(
[id] => 17314432
[patent_doc_number] => 20210403480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => SELECTIVE ESTROGEN RECEPTOR DEGRADERS
[patent_app_type] => utility
[patent_app_number] => 17/465066
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465066 | Selective estrogen receptor degraders | Sep 1, 2021 | Issued |
Array
(
[id] => 20730225
[patent_doc_number] => 12637473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => MDM2 protein degraders
[patent_app_type] => utility
[patent_app_number] => 17/462355
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 37676
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/462355 | MDM2 protein degraders | Aug 30, 2021 | Issued |